Subscribe to RSS
DOI: 10.1055/s-0029-1216640
Synthesis of Fluorinated Pyrrolo[2,3-b]pyridine and Pyrrolo[2,3-d]pyrimidine Nucleosides
Publication History
Publication Date:
12 May 2009 (online)
Abstract
With the purpose of synthesizing novel ADAs (adenosine deaminase) and IMPDH (inosine 5′-monophosphate dehydrogenase) inhibitors the reactions of 5-amino-1-tert-butyl-1-H-pyrrole-3-carbonitrile with fluorinated 1,3- -bielectrophiles were studied. An efficient and convenient synthetical approach to fluorinated pyrrolo[2,3-b]pyridines was developed. The tert-butyl protecting group was successfully removed by treating the pyrrolopyridines or -pyrimidines with 60% sulfuric acid and this was followed by direct glycosylation of the products.
Key words
pyrrole - amine - fluorine - pyridine - annulation - electrophilic aromatic substitution
-
1a
Ugarkar BG.DaRe JM.Kopcho JJ.Browne CE.Schanzer JM.Wiesner JB.Erion MD. J. Med. Chem. 2000, 43: 2883 -
1b
Erion MD.Ugarkar BG.DaRe JM.Castellino AJ.Fujitaki JM.Dixon R.Appleman JR.Wiesner JB. Nucleosides, Nucleotides Nucleic Acids 1997, 16: 1013 -
2a
Seela F.Zulauf M. Nucleosides, Nucleotides Nucleic Acids 1999, 18: 2697 -
2b
Renau TE.Kennedy C.Ptak RG.Breitenbach JM.Drach JC.Townsend LB. J. Med. Chem. 1996, 39: 3470 -
2c
Crawczyk SH.Renau TE.Nassiri MR.Westerman AC.Wotring LL.Drach JC.Townsend LB. J. Med. Chem. 1995, 38: 4115 -
2d
Crawczyk SH.Nassiri MR.Kucera LS.Kern ER.Ptak RG.Wotring LL.Drach JC.Townsend LB. J. Med. Chem. 1995, 38: 4106 -
3a
Nekhai1 S.Bhat UG.Ammosova1 T.Radhakrishnan SK.Jerebtsova M.Niu X.Foster A.Layden TJ.Gartel AL. Oncogene 2007, 26: 3899 -
3b
Mohapatra S, andPledger WJ. inventors; US 2007,238,745. ; Chem. Abstr. 2007, 147, 420059 -
3c
Fujiwara Y.Hosokawa Y.Watanabe K.Tanimura S.Ozaki K.-I.Kohno M. Mol. Cancer Ther. 2007, 6: 1133 -
4a
Porcari AR.Ptak RG.Borysko KZ.Breitenbach JM.Drach JC.Townsend L. J. Med. Chem. 2000, 43: 2457 -
4b
Gartel AL, andRadhakrishnan SK. inventors; WO 2006,116,512. ; Chem. Abstr. 2006, 145, 465765 -
4c
Gordon RK.Ginalski K.Rudnicki WR.Rychlewski L.Pankaskie MC.Bujnicki JM.Chiang PK. Eur. J. Biochem. 2003, 270: 3507 -
5a
Mekouar K,Deziel R,Mounir S, andIyer RP. inventors; WO 03,055,896. ; Chem. Abstr. 2003, 139, 53249 -
5b
Schul W.Liu W.Xu H.-Y.Flamand M.Vasudevan SG. J. Infect. Dis. 2007, 195: 665 -
5c
Maccoss M,Olsen DB,Leone J, andDurette PL. inventors; WO 2006,065,335. ; Chem. Abstr. 2006, 145, 76603 -
5d
Maccoss M, andOlsen DB. inventors; WO 2006,012,078. ; Chem. Abstr. 2006, 144, 192451 -
6a
Hoffman K.Holmes FA.Fraschini G.Esparza L.Frye D.Raber MN.Newman RA.Hortobagyi GN. Cancer Chemother. Pharmacol. 1996, 37: 254 -
6b
O’Connell MJ.Rubin J.Hahn RG.Kvols LK.Moertel CG. Cancer Treat. Rep. 1987, 71: 333 -
6c
Lyss AP.Morrell LE.Perry MC. Proc. Am. Soc. Clin. Oncol. 1991, 10: 120 -
6d
Feun LG.Blessing JA.Barrett RJ.Hanjani PA. Am. J. Clin. Oncol. 1993, 16: 506 - 7
Mantovanini M,Melillo G, andDaffonchio L. inventors; WO 9,504,742. ; Chem. Abstr. 1995, 122, 314537 - 8
Easterwood LM.Veliz EA.Beal PA. J. Am. Chem. Soc. 2000, 122: 11537 - 9
Veliz EA.Easterwood LM.Beal PA. J. Am. Chem. Soc. 2003, 125: 10867 - 10
Cristalli G.Eleuteri A.Vittori S.Volpini R.Camaioni E.Lupidi G. Drug Dev. Res. 1993, 28: 253 -
11a
Lupidi G.Marmocchi F.Cristalli G. Biochem. Mol. Biol. 1998, 46: 1071 -
11b
Lupidi G.Cristalli G.Marmocchi F.Riva F.Grifantini M. J. Enzyme Inhib. Med. Chem. 1985, 1: 67 -
11c
Okamoto A.Tanaka K.Saito I. Bioorg. Med. Chem. Lett. 2002, 12: 97 - 12
Erion MD.Reddy MR. J. Am. Chem. Soc. 1998, 120: 3295 -
13a
Begue J.-P.Bonnet-Delpon D. Chemie Bioorganique et Medicinal du Fluor EDP Sciences; Paris: 2005. p.366 -
13b
Silverman RB. The Organic Chemistry of Drug Design and Drug Action 2nd Ed.: Elsevier Academic Press; Amsterdam: 2004. p.617 - 14
Agarwal RP.Spector T.Parks RE. Biochem. Pharmacol. 1977, 26: 359 -
15a
Iaroshenko VO.Volochnyuk DM.Wang Y.Vovk MV.Boiko VJ.Rusanov EB.Groth UM.Tolmachev AO. Synthesis 2007, 3309 -
15b
Iaroshenko VO.Groth U.Kryvokhyzha NV.Obeid S.Tolmachev AA.Wesch T. Synlett 2008, 343 -
15c
Volochnyuk DM.Pushechnikov AO.Krotko DG.Sibgatulin DA.Kovalyova SA.Tolmachev AA. Synthesis 2003, 1531 -
15d
Vovk MV.Bolbut AV.Boiko VI.Pirozhenko VV.Chernega AN.Tolmachev AA. Chem. Heterocycl. Compd. (Engl. Transl.) 2004, 40: 370 -
15e
Vovk MV.Bol’but AV.Dorokhov VI.Pyrozhenko VV. Synth. Commun. 2002, 32: 3749 -
15f
Iaroshenko VO.Volochnyuk DM.Kryvokhyzha NV.Martyloga A.Sevenard DV.Groth U.Brand J.Chernega AN.Shivanyuk AN.Tolmachev AA. Synthesis 2008, 2337 - 16
De Rosa M.Issac RP.Houghton G. Tetrahedron Lett. 1995, 36: 9261 - 17
Allegretti M.Anacardio R.Cesta MC.Curti R.Mantovanini M.Nano G.Topai A.Zampella Gi. Org. Process Res. Dev. 2003, 7: 209 -
18a
Brodrick A.Wibberley DG. J. Chem. Soc., Perkin Trans. 1 1975, 1910 -
18b
Benoit R.Dupas G.Bourguignon J.Queguiner G. Synthesis 1987, 1124 -
19a
Zanatta N.Amaral SS.Esteves-Souza A.Echevarria A.Brondani PB.Flores DC.Bonacorso HG.Flores AFC.Martins MAP. Synthesis 2006, 2305 -
19b
Kondratov IS.Gerus II.Kacharov AD.Gorbunova MG.Kukhar VP.Froehlich R. J. Fluorine Chem. 2005, 126: 543 -
19c
Matsumoto N.Takahashi M. Tetrahedron Lett. 2005, 46: 5551 -
20a
Dang Q.Brown BS.Erion MD. J. Org. Chem. 1996, 61: 5204 -
20b
Dang Q.Gomez-Galeno JE. J. Org. Chem. 2002, 67: 8703 -
20c
Dang Q.Liu Y.Erion MD. J. Am. Chem. Soc. 1999, 121: 5833 - 21
Vorbruggen H.Ruh-Pohlenz C. Handbook of Nucleoside Synthesis John Wiley & Sons; Chichester: 2001. -
22a
Reid JC.Calvin M. J. Am. Chem. Soc. 1950, 72: 2948 -
22b
Park JD.Brown HA.Lacher JR. J. Am. Chem. Soc. 1953, 75: 4753 -
22c
Pashkevich KI.Khomutov OG.Sevenard DV. Russ. J. Org. Chem. 1998, 34: 1727 ; Zh. Org. Khim. 1998, 34, 1798 -
22d
Sevenard DV.Lork E. J. Fluorine Chem. 2004, 125: 125
References
Crystallographic data (excluding structure
factors) for the structures reported in this paper have been deposited
with the Cambridge Crystallographic Data Centre as supplementary publication
no. CCDC 703680 and CCDC 683574 can be obtained free of charge on
application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44(1223)336033;
e-mail:
deposit@ccdc.cam.ac.uk.